Overview
Although relatively rare, cancer is the leading cause of death from disease among children under 15 in the UK. Because individual types of childhood cancer are uncommon, their signs and symptoms can be unfamiliar to parents and primary care clinicians and are easily mistaken for more common childhood conditions.
How symptoms can present
Health professionals and child cancer charities say symptoms vary by the type of cancer and by the age of the child, and they often overlap with everyday childhood complaints. Symptoms that may prompt further investigation include persistent or unexplained changes such as prolonged fever, unexpected lumps or swellings, unexplained weight loss or fatigue, unusual bruising or bleeding, ongoing pain (including bone or abdominal pain), and neurological signs such as persistent headaches, vomiting or changes to vision or behaviour.
When to seek further assessment
Doctors advise parents to seek medical review when symptoms are persistent, progressive or cannot be explained by a common illness, or when multiple concerning signs appear together. Primary care clinicians are encouraged to consider referral or specialist investigation when red‑flag features are present or symptoms do not resolve in the expected time frame.
Importance of early diagnosis and support
Early recognition and timely referral can improve management options and outcomes for children with cancer. Because delays can occur — partly due to the rarity of childhood cancers and the non‑specific nature of many symptoms — awareness among families and frontline clinicians is important. Support organisations and specialist paediatric teams can provide guidance for parents navigating investigations, treatment and emotional support.
Practical advice for parents and clinicians
Practical steps include keeping a note of worrying symptoms, how long they have lasted and whether they are changing, asking for clarification from a GP if concerns are not resolved, and requesting referral if symptoms persist. Clinicians are reminded to reassess when initial treatment does not lead to expected improvement and to maintain a low threshold for further investigation in the presence of persistent or unexplained signs.